Filing Details
- Accession Number:
- 0000899243-17-018550
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-19 16:05:22
- Reporting Period:
- 2017-07-17
- Filing Date:
- 2017-07-19
- Accepted Time:
- 2017-07-19 16:05:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1496671 | Calithera Biosciences Inc. | CALA | Pharmaceutical Preparations (2834) | 272366329 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1670740 | Keith Orford | C/O Calithera Biosciences, Inc. 343 Oyster Point Blvd. #200 South San Francisco CA 94080 | Sr. Vp, Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-07-17 | 2,120 | $18.31 | 6,879 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on June 16, 2017.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.90 to $18.675, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Includes 6,879 shares acquired under the Company's 2014 Employee Stock Purchase Plan on May 13, 2016, November 15, 2016 and June 9, 2017.
Billionaire Hedge Funds
